Q&A

Elliott Levy on career paths in nephrology, the puzzling nature of kidney diseases, and the elegance of clinical research

"We’re now able to target specific pathways in kidney disease that weren’t even identifiable a decade ago."

Aug 27 •

Tim Fitzpatrick

and

Expert Q&A: Patient-Centric Kidney Innovation

How 7 patient advocates think about progress, pitfalls, and potential in this space

Aug 8 •

Tim Fitzpatrick

,

Terry Litchfield

,

Michael Gilchrist

,

,

Karin Hehenberger

, and

Expert Q&A: Value-Based Kidney Care

How 6 industry experts think about progress, pitfalls, and potential in this space

Apr 25 •

Tim Fitzpatrick

,

Virginia Irwin-Scott

,

,

,

Sri Lekha Tummalapalli

, and

Expert Q&A: Bringing New Devices To Market In Kidney Failure (ESKD)

How 6 device leaders think about progress, pitfalls, and potential in this space

Feb 29 •

Tim Fitzpatrick

,

,

,

,

,

Michael Serle DMSc., MS, PA-C

, and

Cynthia Silva, MD

Expert Q&A: The State & Future of Nutrition in Kidney Health

5 Clinical Experts Share Insights on Pitfalls and Progress in Renal Nutrition

Jan 23 •

Tim Fitzpatrick

,

,

,

, and

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts